The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes

Abstract

As adjuvant therapy, weight loss and metformin were found to be a safe combination strategy that modestly lowered estrogen levels and advantageously affected other biomarkers thought to be on the pathway for reducing breast cancer recurrence and mortality.